HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yang Zheng Selected Research

curcumol

11/2022Effect of Curcumol on NOD-Like Receptor Thermoprotein Domain 3 Inflammasomes in Liver Fibrosis of Mice.
8/2022Gut microbiota combined with metabolomics reveal the mechanism of curcumol on liver fibrosis in mice.
2/2022[Study on mechanism of curcumol against liver fibrosis based on autophagy and apoptosis of hepatic stellate cells].
11/2021Modulation of the VEGF/AKT/eNOS signaling pathway to regulate liver angiogenesis to explore the anti-hepatic fibrosis mechanism of curcumol.
1/2020Effect of Curcumol on the Fenestrae of Liver Sinusoidal Endothelial Cells Based on NF-κB Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yang Zheng Research Topics

Disease

45Neoplasms (Cancer)
07/2022 - 06/2003
28Inflammation (Inflammations)
08/2022 - 10/2012
22Fibrosis (Cirrhosis)
08/2022 - 07/2011
15Squamous Cell Carcinoma of Head and Neck
01/2022 - 10/2010
15Hypoxia (Hypoxemia)
01/2021 - 06/2006
14Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2015
14Myocardial Infarction
10/2021 - 06/2012
13Breast Neoplasms (Breast Cancer)
01/2022 - 03/2003
11Insulin Resistance
01/2022 - 01/2013
11ST Elevation Myocardial Infarction
01/2020 - 01/2017
10Diabetic Cardiomyopathies
02/2022 - 04/2013
10Atherosclerosis
03/2021 - 07/2004
9Carcinogenesis
01/2022 - 11/2009
8Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2012
8Hypertrophy
02/2022 - 03/2012
8Multiple Sclerosis
01/2022 - 05/2018
8Heart Failure
10/2021 - 10/2014
8Cardiomegaly (Heart Hypertrophy)
08/2017 - 04/2013
7Stroke (Strokes)
01/2022 - 10/2017
7Neoplasm Metastasis (Metastasis)
01/2022 - 09/2016
7Ischemia
01/2022 - 11/2013
7Thrombosis (Thrombus)
10/2021 - 04/2015
7Infections
10/2021 - 10/2012
7Obesity
01/2021 - 01/2014
7Body Weight (Weight, Body)
01/2021 - 10/2012
7Carcinoma (Carcinomatosis)
01/2020 - 11/2009
6Sepsis (Septicemia)
11/2021 - 10/2016
6Hyperglycemia
06/2021 - 12/2014
6Myocarditis (Carditis)
10/2020 - 02/2014
6Hypertension (High Blood Pressure)
01/2020 - 03/2012
6Hemorrhage
06/2019 - 06/2012
5Liver Cirrhosis (Hepatic Cirrhosis)
11/2022 - 11/2021
5Wounds and Injuries (Trauma)
10/2022 - 10/2016
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2014
5Neuromyelitis Optica (Devic's Disease)
01/2022 - 10/2019
5Melanoma (Melanoma, Malignant)
01/2022 - 01/2020
5Epilepsy (Aura)
01/2022 - 01/2019
5COVID-19
10/2021 - 01/2020
5Pain (Aches)
09/2021 - 10/2018
5Diabetes Mellitus
05/2021 - 11/2012
5Cardiomyopathies (Cardiomyopathy)
01/2020 - 05/2014
5Acute Coronary Syndrome
01/2020 - 06/2012
5Human Influenza (Influenza)
01/2018 - 01/2013
4Tuberculosis (Tuberculoses)
12/2021 - 03/2015
4Encephalitis (Encephalitis, Rasmussen)
12/2021 - 01/2020
4Acute Kidney Injury (Acute Renal Failure)
01/2021 - 01/2020
4Ischemic Stroke
06/2019 - 07/2017

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
10/2022 - 09/2009
17Biomarkers (Surrogate Marker)IBA
07/2022 - 12/2012
13MicroRNAs (MicroRNA)IBA
05/2022 - 11/2013
12Messenger RNA (mRNA)IBA
04/2022 - 01/2011
9Transcription Factors (Transcription Factor)IBA
05/2022 - 10/2009
9LipidsIBA
01/2022 - 01/2014
8sulforaphaneIBA
02/2022 - 04/2013
8Pharmaceutical PreparationsIBA
01/2022 - 07/2014
7CytokinesIBA
05/2022 - 09/2016
7Insulin (Novolin)FDA Link
01/2022 - 01/2013
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2013
7Immunoglobulin G (IgG)IBA
10/2021 - 05/2013
7MetallothioneinIBA
01/2021 - 01/2014
7Phospholipase DIBA
07/2008 - 03/2003
6Biological ProductsIBA
08/2022 - 11/2014
6Interleukin-6 (Interleukin 6)IBA
05/2022 - 01/2020
6CollagenIBA
02/2022 - 01/2011
6AntioxidantsIBA
06/2021 - 01/2012
61-dodecylpyridoxal (PLD)IBA
07/2008 - 03/2003
5curcumolIBA
11/2022 - 01/2020
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2022 - 01/2014
5omega-Chloroacetophenone (Mace)IBA
01/2022 - 01/2019
5Myelin-Oligodendrocyte GlycoproteinIBA
01/2022 - 10/2019
5AntigensIBA
01/2020 - 09/2016
5DNA (Deoxyribonucleic Acid)IBA
01/2020 - 04/2010
5EnzymesIBA
01/2020 - 06/2011
5Streptozocin (Streptozotocin)FDA Link
01/2020 - 04/2013
5Indicators and Reagents (Reagents)IBA
01/2019 - 06/2003
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 01/2014
5ZincIBA
03/2017 - 01/2008
5p38 Mitogen-Activated Protein KinasesIBA
03/2017 - 06/2016
4InflammasomesIBA
11/2022 - 01/2020
4Atrial Natriuretic Factor (ANF)IBA
02/2022 - 04/2013
4CholesterolIBA
01/2022 - 01/2015
4RNA (Ribonucleic Acid)IBA
01/2022 - 08/2009
4Circular RNAIBA
01/2022 - 01/2020
4HDL CholesterolIBA
10/2021 - 01/2017
4Triglycerides (Triacylglycerol)IBA
10/2021 - 01/2021
4AntibodiesIBA
10/2021 - 05/2013
4LDL Lipoproteins (beta Lipoproteins)IBA
01/2021 - 01/2017
4Amino AcidsFDA Link
01/2021 - 11/2009
4oxidized low density lipoproteinIBA
01/2021 - 01/2018
4Phosphotransferases (Kinase)IBA
01/2020 - 05/2016
4Histones (Histone)IBA
01/2020 - 01/2018
4Therapeutic UsesIBA
01/2020 - 01/2008

Therapy/Procedure

24Therapeutics
01/2022 - 01/2012
13Percutaneous Coronary Intervention
01/2020 - 06/2012
9Stents
10/2021 - 04/2015
8Drug Therapy (Chemotherapy)
05/2022 - 09/2016
4Immunotherapy
01/2022 - 01/2020
4Cardiac Rehabilitation
10/2021 - 01/2019
4Drug-Eluting Stents
10/2021 - 06/2019
4Intraperitoneal Injections
01/2021 - 10/2012